Axcelis Has Limited Near-Term Upside Despite Merger Hopes: Analyst

1. BofA cuts Axcelis rating to Underperform, raising price forecast to $90. 2. Analysts see long-term benefits from merger with Veeco Instruments. 3. Near-term fundamentals for ACLS remain weak with exposure to slow markets. 4. DA Davidson and Benchmark upgraded ACLS rating to Buy, increasing price forecasts. 5. ACLS shares up 3.03% at $81.59 as of recent trading.